ArticleClinical and translational medicine2021

Epigenome screening highlights that JMJD6 confers an epigenetic vulnerability and mediates sunitinib sensitivity in renal cell carcinoma.

Chuanjie Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.